Skip to content

Live Events

Live Events

Live Events

Live Events

Library

By pinki shah / May 14, 2022

Speciality

Author / Speaker

Title of Presentation

Type of Media

Event

2024 Event

Clear

Displaying 501 - 525 of 2,995

«
1
…
19
20
21
22
23
…
120
»

Antibody Drug Conjugates for HER2 Negative Breast Cancer: A Revolution in Chemotherapy for Breast Cancer

Antibody Drug Conjugates for HER2 Negative Breast Cancer: A Revolution in Chemotherapy for Breast Cancer

By: Ruta D. Rao, MD

Triple Negative Breast Cancer Updates

Triple Negative Breast Cancer Updates

By: Sara A. Hurvitz, MD

Triple Negative Breast Cancer Updates

Triple Negative Breast Cancer Updates

By: Sara A. Hurvitz, MD

Metastatic ER Positive Breast Cancer Updates in 2024

Metastatic ER Positive Breast Cancer Updates in 2024

By: Sayeh Lavasani, MD

Surgical management in breast cancer

Surgical management in breast cancer

By: Starr Mautner, MD

Post Neoadjuvant Chemotherapy and the Axilla

Post Neoadjuvant Chemotherapy and the Axilla

By: Terry Mamounas, MD

Denovo Metastatic Breast and the Role of Surgery

Denovo Metastatic Breast and the Role of Surgery

By: Terry Mamounas, MD

Therapeutic and Preventive Vaccines for Triple Negative Breast Cancer

Therapeutic and Preventive Vaccines for Triple Negative Breast Cancer

By: Thomas Budd, MD

Neoadjuvant Updates

Neoadjuvant Updates

By: Tiﬀany Traina, MD

LCIS and ILC – Old Story with New Concerns

LCIS and ILC – Old Story with New Concerns

By: Timothy D’Alfonso, MD

Major Endocrine and Targeted Therapy Advances In the Treatment of HR+/HER2- Breast Cancer

Major Endocrine and Targeted Therapy Advances In the Treatment of HR+/HER2- Breast Cancer

By: Vicente Valero, MD, FACP

HER-2 Disease: Amplification/Overexpression/Mutation in Breast Cancer

HER-2 Disease: Amplification/Overexpression/Mutation in Breast Cancer

By: Virginia Borges, MD

Immunotherapy for Breast Cancer: Efficacy and Toxicity Considerations

Immunotherapy for Breast Cancer: Efficacy and Toxicity Considerations

By: Virginia Borges, MD, MMSc

Metastatic Interrogations and Recommendations

Metastatic Interrogations and Recommendations

By: VK Gadi, MD, PhD

HER Family Transmembrane Proteins & BRCA | An Old Story Turns a New Corner

HER Family Transmembrane Proteins & BRCA | An Old Story Turns a New Corner

By: VK Gadi, MD, PhD

Immunotherapy: Wait, Why Wait

Immunotherapy: Wait, Why Wait

By: VK Gadi, MD, PhD

Transcatheter treatment in breast cancer

Transcatheter treatment in breast cancer

By: Wael Saad, MD

Ablation in Benign & Malignant Breast Disease

Ablation in Benign & Malignant Breast Disease

By: Yolanda Bryce, MD

Advances in the Treatment of CNS Malignancies

Advances in the Treatment of CNS Malignancies

By: Frances Chow, MD

Advances in the Treatment of CNS Malignancies

Advances in the Treatment of CNS Malignancies

By: Frances Chow, MD

Advances in the Treatment of CNS Malignancies

Advances in the Treatment of CNS Malignancies

By: Frances Elaine Chow, MD

Advances in the Treatment of CNS Malignancies

Advances in the Treatment of CNS Malignancies

By: Frances Elaine Chow, MD

Project Optimus and Optimizing Dose and Schedule in Early Phase Clinical Trials

Project Optimus and Optimizing Dose and Schedule in Early Phase Clinical Trials

By: Jan H. Beumer, PhD, PharmD, PhD, DABT

Project Optimus and Optimizing Dose and Schedule in Early Phase Clinical Trials

Project Optimus and Optimizing Dose and Schedule in Early Phase Clinical Trials

By: Jan H. Beumer, PhD, PharmD, PhD, DABT

Phase 1 Exp Cohorts vs Phase 2 Trials

Phase 1 Exp Cohorts vs Phase 2 Trials

By: Jeffrey Longmate, PHD

«
1
…
19
20
21
22
23
…
120
»

← Previous View

6619 South Dixie Highway #341
Miami, FL 33143

Phone: 305.663.1628
Email: info@meccinc.com

Userful Links

Live Events

Categories

About Us

Why Subscribe
About Us
Accreditation

© 2025 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok